Literature DB >> 21660648

Risk factors associated with prevalence and major bacterial causes of mastitis in dromedary camels (Camelus dromedarius) under different production systems.

Sibtain Ahmad1, Muhammad Yaqoob, Muhammad Qamar Bilal, Ghulam Muhammad, Li-Guo Yang, Muhammad Kasib Khan, Muhammad Tariq.   

Abstract

A cross-sectional study was conducted in desert environment of Jhang (Pakistan) from November 2008 to October 2009 on she-camels kept under pastoralist conditions to determine the prevalence of mastitis, impact of risk factors, and isolate the dominant mastitis-causing bacteria on total of 150 lactating she-camels by using clinical examination and surf field mastitis test. From the 150 she-camels examined, 69 (46%) were positive for mastitis at animal level, 12 (8%) clinical, and 57 (38%) subclinical. Age, parity number, stage of lactation, breed, production system, hygiene of milking process, and presence of lesion on udder/teat were found significantly associated (p<0.05) with the prevalence of mastitis in she-camels. There was the lowest prevalence (33.33%; 15 of 45) of mastitis in she-camels of 5-7 years of age, while the highest (80%; 12 of 15) in the animals aged between 14 to 16 years. Stage of lactation significantly affected (p<0.05) and was found to be associated with the prevalence of mastitis being the highest (54.55%; 18 of 33) during the initial stage of lactation (0 to 1 month) followed by last 2 months (10-12 months) as 54.17% and mid-stages (1-3 and 3-10 months) of lactation as 28.57% (6 of 21) and 37.50% (9 of 24), respectively. According to breed of camels, it was noted that the prevalence of mastitis affected significantly (p<0.05) being the highest in crossbred (Desi × Mareecha) as 51.39% (37 of 72) followed in order by Mareecha and Desi as 43.14% and 37.04%, respectively. Staphylococcus (42.19%) and Streptococcus (15.63%) genera were the dominant isolates identified. Good hygiene in milking process, milking clinically infected she-camels at last, culling chronic mastitis carriers, treating clinically infected she-camels, and dry period therapy could reduce the prevalence of contagious mastitis in the study area.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660648     DOI: 10.1007/s11250-011-9895-0

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  10 in total

1.  Mastitis in lactating camels (Camelus dromedarius) in Afar Region, north-eastern Ethiopia.

Authors:  T Bekele; B Molla
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2001 May-Jun       Impact factor: 0.328

2.  Teat lesions and their relationship to intramammary infections on small-scale dairy farms in Kiambu district in Kenya.

Authors:  C M Mulei
Journal:  J S Afr Vet Assoc       Date:  1999-12       Impact factor: 1.474

3.  Comparison of California Mastitis Test (CMT), Somatic Cell Counts (SCC) and bacteriological examinations for detection of camel (Camelus dromedarius) mastitis in Ethiopia.

Authors:  E Abdel Gadir Atif; Goetz Hildebrandt; Josef N Kleer; Bayleyegn Molla; Moses N Kyule; Maximilian P O Baumann
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2006 Jan-Feb       Impact factor: 0.328

4.  Application of the California mastitis test in intramammary Streptococcus agalactiae and Staphylococcus aureus infections of camels (Camelus dromedarius) in Kenya.

Authors:  M Younan; Z Ali; S Bornstein; W Müller
Journal:  Prev Vet Med       Date:  2001-10-11       Impact factor: 2.670

5.  Camel milk for food allergies in children.

Authors:  Yosef Shabo; Reuben Barzel; Mark Margoulis; Reuven Yagil
Journal:  Isr Med Assoc J       Date:  2005-12       Impact factor: 0.892

6.  Detection of subclinical mastitis in dromedary camels (Camelus dromedarius) using somatic cell counts and the N-acetyl-beta-D-glucosaminidase test.

Authors:  A Y Guliye; C Van Creveld; R Yagil
Journal:  Trop Anim Health Prod       Date:  2002-03       Impact factor: 1.559

7.  Relations between udder infection and somatic cells in camel (camelus dromedarius) milk.

Authors:  O A Abdurahman; H Agab; B Abbas; G Aström
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

8.  Mastitis in Camelus dromedarius and the somatic cell content of camels' milk.

Authors:  A I Obied; H O Bagadi; M M Mukhtar
Journal:  Res Vet Sci       Date:  1996-07       Impact factor: 2.534

9.  Milk N-acetyl-beta-D-glucosaminidase and serum albumin as indicators of subclinical mastitis in the camel.

Authors:  O A Abdurahman
Journal:  Zentralbl Veterinarmed A       Date:  1995-12

10.  Udder health problems and major bacterial causes of camel mastitis in Jijiga, Eastern Ethiopia: implication for impacting food security.

Authors:  M Abera; O Abdi; F Abunna; B Megersa
Journal:  Trop Anim Health Prod       Date:  2009-09-03       Impact factor: 1.559

  10 in total
  4 in total

Review 1.  Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle.

Authors:  John Barlow
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-09       Impact factor: 2.673

2.  Incidence, risk factors and economic impact of clinical mastitis in dromedary camel (Camelus dromedarius).

Authors:  Rakesh Ranjan; Shrish D Narnaware; Ved Prakash
Journal:  Trop Anim Health Prod       Date:  2021-12-30       Impact factor: 1.559

3.  Risk factors associated with subclinical mastitis and its effect on physico-mineral features of camel milk.

Authors:  Leyla Hadef; Brahim Hamad; Hebib Aggad
Journal:  Trop Anim Health Prod       Date:  2022-07-04       Impact factor: 1.893

4.  Prevalence of bovine subclinical mastitis, its etiology and diagnosis of antibiotic resistance of dairy farms in four municipalities of a tropical region of Mexico.

Authors:  Jaime Olivares-Pérez; Ahmed Eid Kholif; Saul Rojas-Hernández; Mona Mohamed Mohamed Yasseen Elghandour; Abdelfattah Zeidan Mohamed Salem; Adrian Zaragoza Bastida; David Velázquez-Reynoso; Moisés Cipriano-Salazar; Luis Miguel Camacho-Díaz; María Uxúa Alonso-Fresán; Nicolas DiLorenzo
Journal:  Trop Anim Health Prod       Date:  2015-08-09       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.